Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8459-8467

  Hehir, Kathleen M ^a   Armentano, Donna ^a   Cardoza, Lisa M ^a   Choquette, Terry L ^a   Berthelette, Patricia B ^a   White, Gary A ^a   Couture, Larry A ^a,b   Everton, Maria B ^a   Keegan, Jesse ^a   Martin, John M ^a   Pratt, Denise A ^a   Smith, Michael P ^a   Smith, Alan E ^a   Wadsworth, Samuel C ^a  

^a GENZYME CORPORATION   (United States)

^b Sirna Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; GENE DELETION; GENE MAPPING; GENE REARRANGEMENT; GENE THERAPY; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN MODIFICATION; VIRUS REPLICATION;

EID: 10344254303     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8459-8467.1996     Document Type: Article

References (18)

1. Aiello, L., R. Guilfoyle, K. Huebner, and R. Weinmann. 1979. Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology 94:460-469.
2. Armentano, D., C. S. Sookdeo, K. M. Hehir, R. J. Gregory, J. A. St. George, G. A. Prince, S. C. Wadsworth, and A. E. Smith. 1995. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6:1343-1353.
3. Caravokyri, C., and K. N. Leppard. 1996. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J. Virol. 69:6627-6633.
4. Colby, W. W., and T. Shenk. 1981. Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX. J. Virol. 39:977-980.
5. Donahue, R. E., S. W. Kessler, D. Bodice, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne. M. Raffeld, R. Moen, J. Bacher, K. M. Zsebo, and A. W. Nienhuis. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1124-1135.
6. Ghosh-Choudhury, G., Y. Haj-Ahmad, and F. L. Graham. 1987. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J. 6:1733-1739.
7. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86:3823-3827.
8. Graham, F. L., and L. Prevec. 1991. Adenovirus-bascd expression vectors and recombinant vaccines, p. 363-390. In R. W. Ellis (ed.), Vaccines: new approaches to immunological problems. Butterworth-Hcinemann, Boston.
9. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
10. Hearing, P., R. J. Samulski, W. L. Wishart, and T. J. Shenk. 1987. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J. Virol. 61:2555-2558.
11. Imler, J.-L., C. Chartier, D. Dreyer, A. Dieterle, M. Sainte-Marie, T. Faure, A. Pavirani, and M. Mehtali. 1996. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther. 3:75-84.
12. Krougliak, V., and F. L. Graham. 1995. Development of cell lines capable of complementing El,E4 and protein IX defective adenovirus type 5 mutants, Hum. Gene Ther. 6:1575-1586.
13. Lochmüller, H., A. Jani, J. Huard, S. Prescott, M. Simoneau, B. Massie, G. Karpati, and G. Acsadi. 1994. Emergence of early region i-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (DE1+ DE3) during multiple passages in 293 cells. Hum. Gene Ther. 5:1485-1491.
14. Rich, D. P., L. A. Couture, L. M. Cardoza, V. M. Guiggio, D. Armentano, P. C. Espino, K. Hehir, M. J. Welsh, A. E. Smith, and R. J. Gregory. 1993. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum. Gene Ther. 4:461-476.
15. Spector, D. 1983. The pattern of integration of viral DNA sequences in the adenovirus 5-transformed human cell line. Virology 130:533-538.
16. Vanin, E. F., M. Kaloss, C. Broscius, and A. W. Nienhuis. 1994. Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68:4241-4250.
17. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer corrects the chloride transport defect in patients with cystic fibrosis. Cell 75:207-216.
18. Zabner, J., D. M. Petersen, A. P. Puga, S. M. Graham, M. J. Welsh, L. A. Couture, L. D. Keyes, M. J. Lukason, J. A. St. George, R. J. Gregory, and A. E. Smith. 1994. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6:75-83.